US5976562A - Process for producing bactericidal/fungicidal plastic bodies - Google Patents

Process for producing bactericidal/fungicidal plastic bodies Download PDF

Info

Publication number
US5976562A
US5976562A US08/663,161 US66316196A US5976562A US 5976562 A US5976562 A US 5976562A US 66316196 A US66316196 A US 66316196A US 5976562 A US5976562 A US 5976562A
Authority
US
United States
Prior art keywords
plastic
coated
film
blank
coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US08/663,161
Other languages
English (en)
Inventor
Theodor Krall
J. Peter Guggenbichler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4403016A external-priority patent/DE4403016A1/de
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of US5976562A publication Critical patent/US5976562A/en
Assigned to GUGGENBICHLER, J. PETER reassignment GUGGENBICHLER, J. PETER ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KRALL, THEODOR
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/10Metal compounds
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/16Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/16Heavy metals; Compounds thereof
    • A01N59/20Copper
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16Biologically active materials, e.g. therapeutic substances
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/20Compounding polymers with additives, e.g. colouring
    • C08J3/203Solid polymers with solid and/or liquid additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104Silver, e.g. silver sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606Coatings

Definitions

  • This invention relates to processes for producing plastic bodies that can be further processed, particularly for use in the medical field, and exhibit an antimicrobially effective content of metals or metal compounds (in the following called active agents).
  • materials and/or compounds thereof whose oligodynamical effect is known, such as silver, copper and gold, but also other heavy metals such as zinc and also lanthanides that have an effect on bacteria and/or fungi as desired according to this invention, i.e. they eliminate them, they prevent them from multiplying as well as from sticking to or embedding themselves in the plastic, or at least largely keep them from doing so.
  • Another way of avoiding the high material costs for antimicrobial finishing is not to subject the plastic as a whole to antimicrobial finishing but to coat the finished objects produced from this plastic with active agents.
  • the problem underlying the present invention is thus to provide a method for producing oligodynamically active plastic bodies not exhibiting the aforementioned disadvantages, i.e. that are easy to produce, require only small amounts of oligodynamical metal and/or the compound(s) thereof and uniformly act on all surfaces, also on those that are hard to get to.
  • a method for producing plastic bodies having a content of one or several oligodynamically active metal(s) or metal compounds as an active substance characterized in that the active substance is embedded in the plastic in the form of discrete particles, wherein the amount of active substance is no more than 1.0 wt. %, preferably no more than 0.5 wt. %, based on the total weight of the plastic body, and the maximum size of the discrete active substance particles is less than 500 nm.
  • Active substances in powder form of any kind that are easy to handle are only produced and for sale with finenesses of grain up to the micron range (i.e. ⁇ 1 ⁇ m) and sub-micron range (i.e. >0.1 ⁇ m).
  • the thus achieved specific surface for instance in the case of the finest commercially available silver powder having a rated grain size of 2-3.5 ⁇ m, which of course comprises also a certain portion of coarser particles and sub-micron particles, which is unavoidable, amounts to 0.5 to 1 m 2 /g.
  • Other frequently used and also less expensive silver powders have even larger particles and correspondingly lower specific surfaces.
  • colloidal preparations can generally only be prepared as sols or gels.
  • the thus present portion of protective colloid during further processing and use usually involves considerable undesired side effects.
  • colloidal preparations are often rather unstable and, in addition, often relatively expensive.
  • plastic bodies are therefore preferably produced such that the blank is coated with the bactericidally and/or fungicidally (oligodynamically) active substance by means of a chemical or physical process, the obtained blank (pre-product) is comminuted and/or molten down, from which mass the desired plastic body is then produced according to common methods.
  • Very thin and, depending on the process, fine and even extraordinarily fine structures of the deposited material can be achieved by means of physical and chemical methods for coating surfaces, which structures correspond to or at least come close to the fineness of colloidal preparations. This holds true especially when the deposited layers are very thin.
  • the resulting minimum value of the specific surface is 19 m 2 /g for such coatings, for instance just by mathematic calculation of the outer geometry at a layer thickness of 10 nm e.g. for the deposition of silver.
  • the layer thickness is 1 to 50 nm.
  • the maximum particle size distribution of the active substance is below 100 nm in at least one dimension (e.g. in particles present in the form of flocks or flakes), more preferably 10 nm.
  • the grain size may even be smaller than 1 nm.
  • Crystalline materials (PTFE, some polyimides) must e.g. be comminuted by grinding; remelting is not possible (in practice). They are then shaped as desired by e.g. (pressure) sintering.
  • Plastics having principally a low but most finely dispersed content of metal particles (or particles of metal compounds) with a correspondingly large specific active surface have the same effect as plastics having a considerably higher but less finely dispersed content of metals (or metal compounds) with a correspondingly smaller specific active surface.
  • plastics produced according to the above-mentioned method that for particularly critical cases these plastics may be equipped with metal (or metal compounds) having particles whose size may be influenced for an optimum long-term effect from the very beginning by a suitable process for the production of the layer.
  • the coating can take place on film (see Example), which can then be re-comminuted and further processed. It may also be applied to fibers or granules with the same end result of the production of the desired final concentration of the active substance in the plastic.
  • Plastic blanks that already contain fillers may also be used. Preferred are plastic blanks whose fillers do not considerably alter the chemical and physiological properties of the plastic used as a pre-product. Preferred fillers are those that result in the end products produced therefrom being easily recognizable by means of X-rays and/or having an increased specific weight (e.g. aprons); barium sulfate is frequently used for this purpose in the state of the art. In addition, plastic blanks containing fillers have a larger surface, a fact that is advantageous in the coating of this invention (better dispersion).
  • plastics in the form of films, ribbons (a special kind of film), fibers or granules with one or more active substances in thin layers, preferably with layer thicknesses of between 10 and 100 nm, is possible in various ways using chemical and, above all, physical methods.
  • thermoplastic polyurethane is a preferred plastic raw material. Mention be also made of novel plastics that are similar to common polyurethanes (e.g. "carbothanes").
  • the purpose of the process variants listed in the following is to bring the plastic containing active substance after the coating process into a form that makes it possible to further process it in mixers, kneaders, extruders or other machines to form intermediates and/or to make final processing possible in extruders, injection molding machines or in other equipment, such as (hot-) pressing.
  • the plastic is taken out of the coating equipment, transported, stored and transported to the extruder (packaging under exclusion of air or even under protective gas)
  • the plastic that has (or might have) accepted moisture is once again effectively dried before the extrusion step, preferably right at the extruder.
  • uncoated film or fibers also uncoated granules
  • drying fibers a second time is a little more difficult and drying film a second time directly at the extruder requires special equipment that is unlikely to be available.
  • the surface of the active substance per volume unit plastic that is effective after further processing depends only on the obtained number of layers of active substance per thickness unit plastic after the coating step, i.e. it depends only on the thickness of the film and on whether the film is coated single- or double-sided.
  • the thickness of the coating merely determines the supply of active substance, i.e. the time span how long the system remains effective.
  • the chosen coating method and the parameters used therein especially also the parameters used in the coating process for the pretreatment of the surface (e.g. in glimming or sputter etching), have considerable influence on whether a prepared layer is only seemingly (optically) or really impermeable to water vapor.
  • Uncoated interfacial film may be used to prevent direct contact of the coated surfaces. These uncoated interfacial films must, of course, be taken into account in the balance "coating layers per thickness unit plastic".
  • interfacial film renders the issue of moisture absorbance important for the following process steps, which issue had been almost eliminated by the double-sided coating of the (hygroscopic) plastic film.
  • mass required for such interfacial films relative to the mass of the coated film is smaller by at least a factor of two.
  • the interfacial films too must be dried in some way before they are used, together with the coated plastic film, in a process involving temperatures that are relatively high (for plastics).
  • the chopped product would be rather suitable for being fed into processing machines with appropriate feeding equipment, e.g. "packing screws".
  • Films can be economically produced in large quantities in any desired width and, above all, in almost any desired strength. The latter possibility leads to a very wide variety of possible content of active substance surface per volume unit, which after all determines the effectiveness of the finished plastic.
  • the use of film as a raw material is always to be considered when average-sized active substance surfaces per volume unit plastic are to be produced. The problems of further processing the plastics are acceptable when the produced amount is high enough.
  • Granules can be economically produced in large quantities; however, only in a rather restricted diameter range.
  • the ratio of surface to volume is defined strictly (linear) dependent on the diameter of the granules. This property results in a very reduced possibility of variations for the content of active substance surface per volume unit, which after all determines the effectiveness of the finished plastic.
  • Fibers can be produced somewhat economically in large quantities.
  • Ribbons are a special kind of film. They can be produced economically in large quantities in any desired width and strength. The latter option leads to a very wide variety for the possible content of active substance surface per volume unit plastic, which after all determines the effectiveness of the finished plastic.
  • the use of ribbons as a raw material is always to be considered when average-sized active substance surfaces per volume unit plastic are to be produced. Ribbons can also be sufficiently coated on the narrow sides so that they can then be considered coated all around.
  • ribbons can easily be fed into many extrusion machines without further pre-communition (and the usually following further intermediate steps), which leads to a decisive simplification of the entire manufacturing process of plastics of this invention but of course involves the use of higher amounts of active substance.
  • Double-sided coating of the film with only one active substance makes it possible to eliminate any re-drying steps before further processing and/or final processing when the coating is water-vapor impermeable all around, but it involves a loss of active substance surface in the end product in the course of the further and/or final processing because it cannot be avoided that active substance surfaces are pressed onto one another during further processing.
  • Another embodiment is characterized in that at first a coated plastic blank is produced according to one of the above-described methods but with a higher concentration of one or more antimicrobially active metal(s) and/or metal compound(s); this coated plastic blank is subsequently comminuted or molten down together with uncoated plastic blanks and is finally given the desired shape according to common methods.
  • the uncoated plastic blanks may be made of the same and/or other plastic(s) as the coated plastic blank.
  • Approx. 80 cm 2 -large polyurethane films of 0.25 mm thickness were vapor-deposited with a silver layer of approx. 10 nm thickness in a high-vacuum system for antireflection coating of optical lenses. Under a light microscope the silver layer showed no inherent structure whatsoever, only the unevenness of the film could be seen as unevenness of the coating. Subsequently, the films were comminuted and molten down under stirring at approx. 240° C. Specimen (little platelets) were produced from this mass by means of hot-pressing.
  • the used plastic samples were produced by hand by means of melting and stirring under controlled thermal conditions.
  • each of the samples in the form of sheets having a diameter of 132 mm received 8 cup-shaped indentations having a volume of 0.5 ml each.
  • test sheets were produced from permanently thermoplastic polyurethane films "Platilon U 073", (polyether type) 0.18 mm thick that were coated with
  • test sheets a) and c) were produced twice.
  • Staphylococcus epidermidis 5 ⁇ 10 7 germs/ml
  • Staphylococcus aureus 5 ⁇ 10 7 germs/ml
  • Streptococcus faecalis 5 ⁇ 10 7 germs/ml
  • Escherichia coli 5 ⁇ 10 7 germs/ml
  • Pseudomonas aeruginosa 5 ⁇ 10 7 germs/ml
  • Candida albicans 5 ⁇ 10 7 germs/ml
  • the sheets were positioned in an incubator and kept there for 48 hours.
  • the content of the cups is, judging by visual appearance, dried up.
  • the sheets were removed from the incubator and the cups were refilled with physiological salt solution. After another 15 minutes the newly formed suspension was removed and introduced into nutrient broth.
  • plastic here mainly regarding its capability to accept water and make diffusion of metal ions possible, above all
  • the ratio of active surface per volume unit plastic determine the effectiveness rather than the weight percentage of active substance in the plastic, particularly since in all examined cases this portion is by far less than what it should at least be for demonstrable effectiveness according to available patent publications.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Inorganic Chemistry (AREA)
  • Plant Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Agronomy & Crop Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dentistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Laminated Bodies (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
US08/663,161 1994-02-01 1995-02-01 Process for producing bactericidal/fungicidal plastic bodies Expired - Lifetime US5976562A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE4403016A DE4403016A1 (de) 1994-02-01 1994-02-01 Bakterizide/fungizide Kunststoffkörper
DE4403016 1994-02-01
DE4427829 1994-08-05
DE4427829 1994-08-05
PCT/DE1995/000122 WO1995020878A1 (fr) 1994-02-01 1995-02-01 Procede de fabrication de corps plastiques bactericides/fongicides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US09/431,199 Division US6544536B1 (en) 1994-02-01 1999-11-01 Bactericidal/fungicidal plastic articles

Publications (1)

Publication Number Publication Date
US5976562A true US5976562A (en) 1999-11-02

Family

ID=25933460

Family Applications (2)

Application Number Title Priority Date Filing Date
US08/663,161 Expired - Lifetime US5976562A (en) 1994-02-01 1995-02-01 Process for producing bactericidal/fungicidal plastic bodies
US09/431,199 Expired - Lifetime US6544536B1 (en) 1994-02-01 1999-11-01 Bactericidal/fungicidal plastic articles

Family Applications After (1)

Application Number Title Priority Date Filing Date
US09/431,199 Expired - Lifetime US6544536B1 (en) 1994-02-01 1999-11-01 Bactericidal/fungicidal plastic articles

Country Status (8)

Country Link
US (2) US5976562A (fr)
EP (1) EP0711113B1 (fr)
AT (1) ATE155649T1 (fr)
CA (1) CA2182390C (fr)
DE (1) DE59500419D1 (fr)
DK (1) DK0711113T3 (fr)
ES (1) ES2107913T3 (fr)
WO (1) WO1995020878A1 (fr)

Cited By (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002089766A1 (fr) * 2001-05-08 2002-11-14 Milliken & Company Films de polyurethanne antimicrobiens
US20030049295A1 (en) * 1999-07-30 2003-03-13 Guggenbichler J. Peter Process for preparing antimicrobial plastic bodies having improved long-time performance
US6579539B2 (en) 1999-12-22 2003-06-17 C. R. Bard, Inc. Dual mode antimicrobial compositions
US6596401B1 (en) 1998-11-10 2003-07-22 C. R. Bard Inc. Silane copolymer compositions containing active agents
US6716895B1 (en) 1999-12-15 2004-04-06 C.R. Bard, Inc. Polymer compositions containing colloids of silver salts
US20040220534A1 (en) * 2003-04-29 2004-11-04 Martens Paul W. Medical device with antimicrobial layer
US20050246849A1 (en) * 2004-05-10 2005-11-10 Minkler Douglas J Sanitizing handle for cleaning tool
US20060134313A1 (en) * 2002-09-10 2006-06-22 Josef-Peter Guggenbichler Methods for producing an anti-microbial plastic product
US20060275353A1 (en) * 2002-05-31 2006-12-07 Nicholas V. Perricone Stable topical drug delivery compositions
US20070095191A1 (en) * 2005-10-31 2007-05-03 Dennis Moss Bagel sandwich knife
US20080127497A1 (en) * 2005-10-31 2008-06-05 Dennis Moss Blade assembly
US20090253848A1 (en) * 2008-04-08 2009-10-08 Bayer Materialscience Ag Aqueous silver-containing nonionic polyurethane dispersions
US20090252804A1 (en) * 2008-04-08 2009-10-08 Bayer Materialscience Ag Medical devices with an antibacterial polyurethaneurea coating
US20090252699A1 (en) * 2008-04-08 2009-10-08 Bayer Materialscience Ag Medical devices with an antimicrobial polyurethane coating
US20100139505A1 (en) * 2007-05-11 2010-06-10 Tobias Graf Component for a machine used for processing foods
US7820284B2 (en) 2001-12-03 2010-10-26 C.R. Bard Inc. Microbe-resistant medical device, microbe-resistant polymeric coating and methods for producing same
US20110015615A1 (en) * 2007-07-26 2011-01-20 Spiegelberg (Gmbh & Co.) Kg Antimicrobial plastics product and process for production thereof
US8034454B2 (en) 1999-12-15 2011-10-11 C.R. Bard, Inc. Antimicrobial compositions containing colloids of oligodynamic metals
US8631583B2 (en) 2005-10-31 2014-01-21 Dennis Moss Bagel slicer
US8668937B2 (en) 2011-03-17 2014-03-11 Transdermal Biotechnology, Inc. Topical nitric oxide systems and methods of use thereof
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US9084870B2 (en) 1999-07-19 2015-07-21 Avent, Inc. Catheter for uniform delivery of medication
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9585931B2 (en) 2013-03-13 2017-03-07 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9597400B2 (en) 2013-03-13 2017-03-21 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9597401B2 (en) 2013-03-13 2017-03-21 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US10034914B2 (en) 2013-03-13 2018-07-31 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US10104995B2 (en) 2014-01-09 2018-10-23 Goverre, Inc. Closeable beverage lid
US10226511B2 (en) 2013-03-13 2019-03-12 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
EP1928531B1 (fr) * 2005-08-31 2020-04-29 Avent, Inc. Catheter antimicrobien
CN113631202A (zh) * 2019-03-29 2021-11-09 卡尔·莱宾格医疗技术有限责任两合公司 具有内在抗微生物有效性的植入物和用于制造其的方法

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19758598B4 (de) * 1997-11-20 2005-09-01 Bechert, Thorsten, Dr. Verfahren zur Prüfung von Materialien hinsichtlich ihrer potentiellen antimikrobiellen Wirksamkeit und der Proliferation von Zellen auf ihrer Oberfläche
EP1066825A1 (fr) * 1999-06-17 2001-01-10 The Procter & Gamble Company Produit antimicrobien pour les soins du corps
WO2001009229A1 (fr) 1999-07-30 2001-02-08 Guggenbichler J Peter Procede de fabrication de corps en plastique anti-microbiens a comportement ameliore sur la duree
DE10043151A1 (de) * 2000-08-31 2002-03-28 Peter Steinruecke Knochenzement mit antimikrobieller Wirksamkeit
DE10145275A1 (de) * 2001-09-14 2003-04-03 Coronet Werke Gmbh Monofil mit antimikrobiellen Eigenschaften, Verwendung solcher Monofile als Borstenmaterial und Bürste oder Pinsel mit diesem Borstenmaterial
DE10146050B4 (de) 2001-09-18 2007-11-29 Bio-Gate Ag Verfahren zur Herstellung eines antimikrobiellen Kleb- und Beschichtungsstoffes
ES2362412T3 (es) * 2002-12-31 2011-07-05 Transdermal Biotechnology, Inc. Composiciones estables para el suministro tópico de fármacos.
DE10340277B4 (de) * 2003-08-29 2006-11-23 Bio-Gate Bioinnovative Materials Gmbh Körperpflegemittel mit Silber-Agglomeraten
WO2006088288A1 (fr) * 2005-02-19 2006-08-24 Won-Dong Yang Aiguilles medicales possedant une fonction antibacterienne et anesthesiante
DE102005053295C5 (de) * 2005-11-08 2013-03-07 Spiegelberg GmbH & Co. KG Verfahren zur Herstellung eines steril verpackten, metallhaltigen Kunststoffkörpers mit antimikrobiell wirkender Oberfläche
DE102006022236A1 (de) * 2006-02-20 2007-08-30 Rehau Ag + Co Profilleiste
EP1820663B1 (fr) * 2006-02-20 2011-04-06 REHAU AG + Co Baguette avec materiél oligodynamique
EP2058379A1 (fr) 2007-11-09 2009-05-13 ACTEGA DS GmbH Procédé de fabrication d'une fermeture de récipient
EP2108382A1 (fr) 2008-04-08 2009-10-14 Bayer MaterialScience AG Solution de polyuréthane-urée contenant de l'argent
DE102011102635B4 (de) 2011-05-27 2014-02-13 Spiegelberg GmbH & Co. KG Verfahren zur Herstellung eines antimikrobiellen Kunststoffproduktes unter Verwendung eines Reduktons
DE102011102636B3 (de) 2011-05-27 2012-11-22 Spiegelberg GmbH & Co. KG Verfahren zur Herstellung eines antimikrobiellen Kunststoffproduktes
DE102011107637A1 (de) 2011-07-18 2013-01-24 Neschen Ag Inzisionsfolie und Verfahren zu deren Herstellung
WO2014209095A1 (fr) 2013-06-25 2014-12-31 Servicios Administrates Penoles, S.A. De C.V. Additif bactériostatique et fongistatique en mélange maître pour une application sur des plastiques et procédé d'obtention de celui-ci
EP4062868A3 (fr) 2015-03-30 2022-12-21 C. R. Bard, Inc. Application d'agents antimicrobiens sur des dispositifs médicaux
DE102017121439A1 (de) 2017-09-15 2019-03-21 Hecosol Gmbh Anti-mikrobielle Beschichtung
EP3907261A1 (fr) 2020-05-06 2021-11-10 Hecosol GmbH Utilisation de revêtement antimicrobien

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180585A (en) * 1991-08-09 1993-01-19 E. I. Du Pont De Nemours And Company Antimicrobial compositions, process for preparing the same and use
US5236649A (en) * 1988-12-23 1993-08-17 The Dow Chemical Extrudable thermoplastic particulates
US5418056A (en) * 1989-11-24 1995-05-23 Mitsuboshi Belting Ltd. Polymer composite with dispersed fine grains and a method for manufacturing the same
US5538766A (en) * 1992-07-06 1996-07-23 The United States Of America As Represented By The Administrator Of The National Aeronautics & Space Administration Method for retarding oxidation of an organic substrate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3837125A1 (de) * 1988-11-02 1990-05-03 Signode System Gmbh Verfahren zur herstellung von formkoerpern aus metall und einem thermoplastischen kunststoff
DE3942112A1 (de) * 1989-12-20 1991-06-27 Braun Melsungen Ag Medizinische vorrichtung mit einem oligodynamisch wirkenden material
US5681575A (en) * 1992-05-19 1997-10-28 Westaim Technologies Inc. Anti-microbial coating for medical devices

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236649A (en) * 1988-12-23 1993-08-17 The Dow Chemical Extrudable thermoplastic particulates
US5418056A (en) * 1989-11-24 1995-05-23 Mitsuboshi Belting Ltd. Polymer composite with dispersed fine grains and a method for manufacturing the same
US5180585A (en) * 1991-08-09 1993-01-19 E. I. Du Pont De Nemours And Company Antimicrobial compositions, process for preparing the same and use
US5538766A (en) * 1992-07-06 1996-07-23 The United States Of America As Represented By The Administrator Of The National Aeronautics & Space Administration Method for retarding oxidation of an organic substrate

Cited By (119)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596401B1 (en) 1998-11-10 2003-07-22 C. R. Bard Inc. Silane copolymer compositions containing active agents
US9084870B2 (en) 1999-07-19 2015-07-21 Avent, Inc. Catheter for uniform delivery of medication
US20030049295A1 (en) * 1999-07-30 2003-03-13 Guggenbichler J. Peter Process for preparing antimicrobial plastic bodies having improved long-time performance
US20070194483A1 (en) * 1999-07-30 2007-08-23 Guggenbichler J P Process for preparing antimicrobial plastic bodies having improved long-time performance
US8075823B2 (en) * 1999-07-30 2011-12-13 Guggenbichler J Peter Process for preparing antimicrobial plastic bodies having improved long-time performance
US6716895B1 (en) 1999-12-15 2004-04-06 C.R. Bard, Inc. Polymer compositions containing colloids of silver salts
US8034454B2 (en) 1999-12-15 2011-10-11 C.R. Bard, Inc. Antimicrobial compositions containing colloids of oligodynamic metals
US6579539B2 (en) 1999-12-22 2003-06-17 C. R. Bard, Inc. Dual mode antimicrobial compositions
WO2002089766A1 (fr) * 2001-05-08 2002-11-14 Milliken & Company Films de polyurethanne antimicrobiens
US7820284B2 (en) 2001-12-03 2010-10-26 C.R. Bard Inc. Microbe-resistant medical device, microbe-resistant polymeric coating and methods for producing same
US9060925B2 (en) 2002-05-31 2015-06-23 Transdermal Biotechnology, Inc. Methods of delivering stable topical drug compositions
US9050248B2 (en) 2002-05-31 2015-06-09 Transdermal Biotechnology, Inc. Methods of delivering stable topical drug compositions
US20060275353A1 (en) * 2002-05-31 2006-12-07 Nicholas V. Perricone Stable topical drug delivery compositions
US20110123577A1 (en) * 2002-05-31 2011-05-26 Perricone Nicholas V Method Of Delivering Stable Topical Drug Compositions
US20060134313A1 (en) * 2002-09-10 2006-06-22 Josef-Peter Guggenbichler Methods for producing an anti-microbial plastic product
US20100068296A1 (en) * 2002-09-10 2010-03-18 Antimicrobial Argentum Technologies Methods for producing an anti-microbial plastic product
US20040220534A1 (en) * 2003-04-29 2004-11-04 Martens Paul W. Medical device with antimicrobial layer
US20050246849A1 (en) * 2004-05-10 2005-11-10 Minkler Douglas J Sanitizing handle for cleaning tool
EP1928531B1 (fr) * 2005-08-31 2020-04-29 Avent, Inc. Catheter antimicrobien
US20080127497A1 (en) * 2005-10-31 2008-06-05 Dennis Moss Blade assembly
US8631583B2 (en) 2005-10-31 2014-01-21 Dennis Moss Bagel slicer
US20070095191A1 (en) * 2005-10-31 2007-05-03 Dennis Moss Bagel sandwich knife
US20100139505A1 (en) * 2007-05-11 2010-06-10 Tobias Graf Component for a machine used for processing foods
US20110015615A1 (en) * 2007-07-26 2011-01-20 Spiegelberg (Gmbh & Co.) Kg Antimicrobial plastics product and process for production thereof
US8673441B2 (en) 2007-07-26 2014-03-18 Spiegelberg (Gmbh & Co.) Kg Antimicrobial plastics product and process for production thereof
US20090252804A1 (en) * 2008-04-08 2009-10-08 Bayer Materialscience Ag Medical devices with an antibacterial polyurethaneurea coating
US20090253848A1 (en) * 2008-04-08 2009-10-08 Bayer Materialscience Ag Aqueous silver-containing nonionic polyurethane dispersions
US20090252699A1 (en) * 2008-04-08 2009-10-08 Bayer Materialscience Ag Medical devices with an antimicrobial polyurethane coating
US9937202B2 (en) 2011-03-17 2018-04-10 Transdermal Biotechnology, Inc. Topical nitric oxide systems and methods of use thereof
US8668937B2 (en) 2011-03-17 2014-03-11 Transdermal Biotechnology, Inc. Topical nitric oxide systems and methods of use thereof
US9517179B2 (en) 2011-03-17 2016-12-13 Transdermal Biotechnology, Inc. Topical nitric oxide systems and methods of use thereof
US9827266B2 (en) 2012-09-19 2017-11-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US9480705B2 (en) 2012-09-19 2016-11-01 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US9198933B2 (en) 2012-09-19 2015-12-01 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US9198931B2 (en) 2012-09-19 2015-12-01 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US9198932B2 (en) 2012-09-19 2015-12-01 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US9198930B2 (en) 2012-09-19 2015-12-01 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US9198854B2 (en) 2012-09-19 2015-12-01 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US9198970B2 (en) 2012-09-19 2015-12-01 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US9198853B2 (en) 2012-09-19 2015-12-01 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US9205043B2 (en) 2012-09-19 2015-12-08 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US10034896B2 (en) 2012-09-19 2018-07-31 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US9295638B2 (en) 2012-09-19 2016-03-29 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US10034898B2 (en) 2012-09-19 2018-07-31 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US10034897B2 (en) 2012-09-19 2018-07-31 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US9968634B2 (en) 2012-09-19 2018-05-15 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US9968635B2 (en) 2012-09-19 2018-05-15 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US9950004B2 (en) 2012-09-19 2018-04-24 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US9844565B2 (en) 2012-09-19 2017-12-19 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US9795632B2 (en) 2012-09-19 2017-10-24 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US9480711B2 (en) 2012-09-19 2016-11-01 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US9480708B2 (en) 2012-09-19 2016-11-01 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US9480706B2 (en) 2012-09-19 2016-11-01 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US9480707B2 (en) 2012-09-19 2016-11-01 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US9480710B2 (en) 2012-09-19 2016-11-01 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US9480709B2 (en) 2012-09-19 2016-11-01 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US9597400B2 (en) 2013-03-13 2017-03-21 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9872818B2 (en) 2013-03-13 2018-01-23 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9480642B2 (en) 2013-03-13 2016-11-01 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9498535B2 (en) 2013-03-13 2016-11-22 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9585931B2 (en) 2013-03-13 2017-03-07 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9585817B2 (en) 2013-03-13 2017-03-07 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9585829B2 (en) 2013-03-13 2017-03-07 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9597401B2 (en) 2013-03-13 2017-03-21 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9636291B2 (en) 2013-03-13 2017-05-02 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9682102B2 (en) 2013-03-13 2017-06-20 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9687504B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9694029B2 (en) 2013-03-13 2017-07-04 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9694083B2 (en) 2013-03-13 2017-07-04 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9700626B2 (en) 2013-03-13 2017-07-11 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9717680B2 (en) 2013-03-13 2017-08-01 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9757467B2 (en) 2013-03-13 2017-09-12 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9827316B2 (en) 2013-03-13 2017-11-28 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9844506B2 (en) 2013-03-13 2017-12-19 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9439926B2 (en) 2013-03-13 2016-09-13 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9913793B2 (en) 2013-03-13 2018-03-13 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9931370B2 (en) 2013-03-13 2018-04-03 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9937221B2 (en) 2013-03-13 2018-04-10 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9943562B2 (en) 2013-03-13 2018-04-17 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9956290B2 (en) 2013-03-13 2018-05-01 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US10028994B2 (en) 2013-03-13 2018-07-24 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US10034914B2 (en) 2013-03-13 2018-07-31 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US10034828B2 (en) 2013-03-13 2018-07-31 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US10034944B2 (en) 2013-03-13 2018-07-31 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US10064955B2 (en) 2013-03-13 2018-09-04 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US10071117B2 (en) 2013-03-13 2018-09-11 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US10080768B2 (en) 2013-03-13 2018-09-25 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US10155048B2 (en) 2013-03-13 2018-12-18 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US10188603B2 (en) 2013-03-13 2019-01-29 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US10213457B2 (en) 2013-03-13 2019-02-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US10226511B2 (en) 2013-03-13 2019-03-12 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US10104995B2 (en) 2014-01-09 2018-10-23 Goverre, Inc. Closeable beverage lid
CN113631202A (zh) * 2019-03-29 2021-11-09 卡尔·莱宾格医疗技术有限责任两合公司 具有内在抗微生物有效性的植入物和用于制造其的方法

Also Published As

Publication number Publication date
CA2182390A1 (fr) 1995-08-10
DE59500419D1 (de) 1997-08-28
CA2182390C (fr) 2006-12-19
US6544536B1 (en) 2003-04-08
WO1995020878A1 (fr) 1995-08-10
DK0711113T3 (da) 1997-09-22
EP0711113A1 (fr) 1996-05-15
ES2107913T3 (es) 1997-12-01
EP0711113B1 (fr) 1997-07-23
ATE155649T1 (de) 1997-08-15

Similar Documents

Publication Publication Date Title
US5976562A (en) Process for producing bactericidal/fungicidal plastic bodies
US10299472B2 (en) Coating material
US20180055975A1 (en) Method for Producing a Dispersion Containing Silver Nanoparticles and Use of a Mixture Containing Silver Nanoparticles as a Coating Agent
Jadalannagari et al. Antimicrobial activity of hemocompatible silver doped hydroxyapatite nanoparticles synthesized by modified sol–gel technique
EP2789235B1 (fr) Methode de préparation de nanoparticules d'argent
EP2136621B1 (fr) Materiau antimicrobien
AU604724B2 (en) Polymer containing amorphous aluminosilicate particles and process for producing the same
EP3575263B1 (fr) Procédé de production d'un additif bactériostatique et fongistatique dans un mélange maître pour application dans des matières plastiques
KR20090131847A (ko) 항균성 고분자 및 그 제조방법
EP2515642B1 (fr) Nanoparticules ayant des propriétés fongicides, leur procede de preparation et leur utilisation pour la fabrication des différents articles.
CN101180372A (zh) 含银溶液、包含该溶液的抗菌树脂组合物以及用抗菌树脂涂敷的钢板
JPS62503096A (ja) ガラス微小泡及び凝集性物品
DE4403016A1 (de) Bakterizide/fungizide Kunststoffkörper
Kaygusuz et al. Antimicrobial nano-Ag-TiO2 coating for lining leather
Li et al. Controllable deposition of Ag nanoparticles on various substrates via interfacial polyphenol reduction strategy for antibacterial application
Köse et al. Improving properties of biodegradable chitosan/PVA composite polymers via novel designed ZnO particles
MXPA05010566A (es) Metodo antibiotico para partes de refrigerador utilizando sustancia antibiotica.
Scacchetti et al. Antimicrobial properties of composites of chitosan-silver doped zeolites
Chauhan et al. Polymer–metal nanocomposites with antimicrobial activity
CN115109342B (zh) 聚丙烯塑料及其制备方法
Abdelghany et al. WITHDRAWN: Spectroscopic and antibacterial speculation of silver nanoparticles modified chitosan/polyvinyl alcohol polymer blend
KR100196561B1 (ko) 항균성 폴리머의 제조방법
EP3816126A1 (fr) Matériau composite antmicrobien
JPH04231063A (ja) 抗菌性組成物
Ahmed et al. Characterization of Aluminum-Silver nanofilms and their effects as antimicrobial and degradation of organic compounds

Legal Events

Date Code Title Description
STCF Information on status: patent grant

Free format text: PATENTED CASE

AS Assignment

Owner name: GUGGENBICHLER, J. PETER, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KRALL, THEODOR;REEL/FRAME:013295/0174

Effective date: 20010926

FPAY Fee payment

Year of fee payment: 4

FEPP Fee payment procedure

Free format text: PAT HOLDER NO LONGER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: STOL); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12